XML 31 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity
6 Months Ended
Apr. 30, 2021
Stock Repurchase Program [Abstract]  
Stock Repurchase Program [Text Block] Stockholders’ Equity
Stock Repurchase Program
On March 10, 2020, our Board of Directors terminated our existing 20 million share repurchase program, which was authorized in December 2019, and authorized, under a new repurchase program, the repurchase of 20 million shares of our common stock in open market transactions, privately negotiated transactions (including accelerated share repurchases), issuer tender offers or other financial arrangements or transactions, in each case for general corporate purposes, including to obtain shares for the Company’s equity award and other employee benefit plans. Our Board of Directors did not fix any expiration date for this repurchase program.
The table below provides, for the periods indicated, information about our share repurchase programs:
 Three months ended April 30,Six months ended April 30,
 2021202020212020
Number of shares purchased (in thousands)4,252 4,032 15,938 
Average price per share$55.11 $37.05 $44.56 $39.75 
Remaining authorization at April 30 (in thousands)15,952 19,998 15,952 19,998 
Cash Dividends
On March 9, 2021, our Board of Directors approved an increase in our quarterly cash dividend from $0.11 per share to $0.17 per share. During the three months ended April 30, 2021 and 2020, we declared and paid cash dividends of $0.17 and $0.11 per share, respectively, to our shareholders. During the six months ended April 30, 2021 and 2020, we declared and paid cash dividends of $0.28 and $0.22 per share, respectively, to our shareholders.
Accumulated Other Comprehensive Loss
The changes in each component of accumulated other comprehensive loss (“AOCL”), for the periods indicated, were as follows (amounts in thousands):
Three months ended April 30,Six months ended April 30,
2021202020212020
Employee Retirement Plans
Beginning balance$(6,864)$(5,553)$(7,198)$(5,831)
Gains (losses) arising during the period— — — — 
Less: Tax (expense) benefit— — — — 
Net gains (losses) arising during the period— — — — 
Gains reclassified from AOCL to net income (1)
450 373 900 746 
Less: Tax expense (2)
(115)(95)(231)(190)
Net gains reclassified from AOCL to net income335 278 669 556 
Other comprehensive income, net of tax335 278 669 556 
Ending balance$(6,529)$(5,275)$(6,529)$(5,275)
Derivative Instruments
Beginning balance$378 $— $— $— 
Gains on derivative instruments5,474 — 5,972 — 
Less: Tax expense(1,395)— (1,523)— 
Net gains on derivative instruments4,079 — 4,449 — 
Gains reclassified from AOCL to net income (3)
32 — 42 — 
Less: Tax expense (2)
(8)— (10)— 
Net gains reclassified from AOCL to net income24 — 32 — 
Other comprehensive income, net of tax4,103 — 4,481 — 
Ending balance$4,481 $— $4,481 $— 
Total AOCL ending balance$(2,048)$(5,275)$(2,048)$(5,275)
(1) Reclassified to “Other income – net”
(2) Reclassified to “Income tax provision”
(3) Reclassified to “Cost of revenues – home sales”